Filing Flows › Bruker (BRKR) › Q2 2025
Bruker (BRKR) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 6, 2025
Bruker (BRKR) reported revenue of $797M for the second quarter 2025 (Q2 2025), -0.4% from a year earlier and -0.5% from the quarter before. Operating margin was 1.5%, net earnings $7.6M (1.0% of revenue).
Bruker, Q2 2025: revenue $797M (-0.4% year over year), operating margin 1.5%, net earnings $7.6M, operating cash flow −$128M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $797M | -0.5% | -0.4% |
| Gross profit | $358M | -9% | -7% |
| Operating profit | $11.9M | -63% | -75% |
| Net earnings | $7.6M | -56% | 0% |
| Operating cash flow | −$128M | -296% | — |
What changed
Revenue was $797.4M in Q2 2025, roughly flat year over year and roughly flat from the previous quarter. Bsi Calid was the largest line at 36% of revenue. Bsi Biospin lost $22.2M year over year (down 10%), 673% of the total change.
Gross margin was 44.9%, down 3.1 points from a year earlier. Operating profit was $11.9M, a 1.5% margin (down 4.5 points year over year). Operating expenses grew 3% against flat revenue. Net earnings were $7.6M, roughly flat year over year ($4.2M including minority interests, which bore $3.4M of losses). The tax line was a benefit of $3.1M on pre-tax earnings of $1.1M.
Operating cash flow was −$127.5M. Non-cash charges added back $56.1M of depreciation and amortization and $5.7M of share-based compensation. Working capital and other items used $193.5M. Capital expenditures of $21.3M exceeded it, leaving free cash flow of −$148.8M.
Questions
What was Bruker's revenue in the second quarter 2025?
Bruker (BRKR) reported revenue of $797M for the second quarter 2025 (Q2 2025), -0.4% from a year earlier and -0.5% from the quarter before.
Was Bruker profitable in the second quarter 2025?
Operating profit was $11.9M (1.5% of revenue) and net earnings $7.6M.
Source: Bruker 10-Q on SEC EDGAR.